San Diego Padres star Fernando Tatis Jr. reacted to teammate Jackson Merrill signing a long-term contract extension with the ...

Subway’s sales and the number of locations have been in a downward spiral -- facts made even more evident by growth ... New endorsers are Padres OF Fernando Tatís Jr. (Arrowhead); Astros DH Yordan ...

After both Fernando Tatis Jr and Jake Cronenworth left Wednesday's game due to injury, the players got a crucial update.

Jackson Merrill was placed on the injured list, Jake Cronenworth left the loss against the Athletics in the third inning, and ...

The injury to Tatis Jr is accompanied by center fielder Jackson Merrill going on the injured list. Second baseman Jake ...

San Diego Padres manager Mike Shildt provided an update on outfielder Fernando Tatis Jr., who left Tuesday's game early with an injury. He also provided an update on the injured Jake Cronenworth.

More news: Padres Right With Dodgers in First MLB Power Rankings of 2025 Season Fernando Tatis Jr. was known to have had a close relationship while the two outfielders played side by side at Petco ...

Fernando Tatis Jr. got the San Diego Padres off to a hot start in the opening inning against the Atlanta Braves on Sunday night, getting things going with a leadoff double. Tatis didn't put the ...

San Diego Padres have started the 2025 season on a strong note, completing a sweep over the Atlanta Braves, with Fernando Tatis Jr. taking on a new role in the lineup. The 26-year-old has been one ...

Facing injury struggles, Fernando Tatis Jr. seeks guidance from teammate Manny Machado to revamp his training strategy. Learning the importance of balanced workload and recovery from Machado ...

Fernando Tatis Jr. has become one of the richest MLB players with a $340 million contract with the San Diego Padres, augmented by profitable endorsements. As of 2025, his annual salary averages $ ...

Atlanta Braves All-Star outfielder Jurickson Profar joined former San Diego Padres teammate Fernando Tatis Jr. among the players suspended for performance-enhancing drugs in recent years.